Gentherm Inc · NASDAQ:THRM

Gentherm — Q3 2020 Earnings Presentation

15 slides from Gentherm's earnings presentation, Oct 29, 2020

  1. Slide 1: 2020 Third Quarter Results

    2020 Third Quarter Results Gentherm, Inc. October 29, 2020 Exhibit 99.2

  2. Slide 2: Forward-Looking Statement

    Forward-Looking Statement Except for historical information contained herein, statements in this presentation are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Genthe

  3. Slide 3: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures* In addition to the results reported in accordance with GAAP throughout this presentation, the Company has provided information regarding Adjusted EBITDA and Adjusted EPS, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings (loss) bef

  4. Slide 4: 3Q 2020 Highlights

    3Q 2020 Highlights Continued strong execution delivered record performance Highest total company revenue in 2 years Record Automotive revenue in company history Double digit revenue growth in Medical year over year Highest gross margin and gross margin rate in 3 years Record operating income in comp

  5. Slide 5: Automotive 3Q 2020 Highlights

    Automotive 3Q 2020 Highlights Continued momentum in Automotive 29 Vehicle launches with 14 OEMs Multiple CCS® product launches Buick Envision Jeep Compass Kia Sorento Mercedes S-Class Grew innovative, combined steering wheel heat and hands-on-detection sensor with VW Began phase three advanced Clima

  6. Slide 6: Automotive Awards

    Automotive Awards Continued widespread adoption of Gentherm technologies $80M in awards in 3Q across 6 OEMs CCS®, Seat Heaters and Thermal Cup awards with BMW First CCS® award with PSA in China Steering Wheel Heat awards with FCA and one of the largest EV manufacturers Air-cooling battery thermal ma

  7. Slide 7: Medical 3Q 2020 Highlights

    Medical 3Q 2020 Highlights Continued strong growth in the Medical business Revenue up 17% year over year Strong growth in Stihler products reflecting acquisition synergy Continued growth in Blanketrol® and Hemotherm® equipment driven by international markets U.S. FDA 510(k) clearance of ASTOPAD® pat

  8. Slide 8: Focused Growth

    Focused Growth Introduce Innovative Microclimate Solution - ClimateSenseTM Drive Battery Thermal Management Expand Patient Thermal Solutions Accelerate Core Automotive Climate and Comfort Growth Enabled by Electronics and Software Systems

  9. Slide 9: Summary

    Summary Well positioned to deliver long-term shareholder returns 3Q results demonstrate continued successful execution of our strategic plan Focused growth Realigned cost structure Bringing innovative solutions to market Strong balance sheet and financial resources

  10. Slide 10: Selected Income Statement Data

    Selected Income Statement Data 2020 2019 2020 2019 Product Revenues $259,540 $240,056 $624,214 $741,303 Gross Margin 82,605 74,692 175,407 222,713 Gross Margin % 31.8% 31.1% 28.1% 30.0% Operating Expenses 44,099 54,363 128,097 160,482 Operating Income 38,506 20,329 47,310 62,231 Adjusted EBITDA 50,1

  11. Slide 11: Selected Balance Sheet Data

    Selected Balance Sheet Data September 30, 2020 December 31, 2019 Cash and Cash Equivalents $226,533 $50,443 Restricted Cash 2,506 2,505 Total Assets 921,447 727,386 Debt 195,561 80,624 Current 2,500 2,500 Non-Current 193,061 78,124 Revolving LOC Availability 221,489 392,325 Total Liquidity 448,022 4

  12. Slide 12: Gentherm

    ((l)) GENTHERM

  13. Slide 13: Reconciliation of Net Income to Adjusted EBITDA

    Reconciliation of Net Income to Adjusted EBITDA 2020 2019 2020 2019 Net Income $24,146 $15,887 $25,697 $27,052 Add Back: Income Tax Expense 9,603 6,771 15,214 19,214 Interest Expense 1,259 1,148 3,368 3,756 Depreciation and Amortization 10,129 10,974 30,129 33,048 Adjustments: Restructuring Expenses

  14. Slide 14: Reconciliation of Adjusted EPS

    Reconciliation of Adjusted EPS 2020 2019 2020 2019 Diluted EPS - As Reported $0.73 $0.48 $0.78 $0.81 Acquisition Transaction Expenses 0.02 — 0.02 0.01 Non-Cash Purchase Accounting Impacts 0.07 0.08 0.20 0.22 Unrealized Currency Loss (Gain) 0.12 (0.11) 0.20 (0.13) Restructuring Expenses 0.01 0.26 0.1

  15. Slide 15: Gentherm - Technology to the next degree

    (()))) GENTHERM Technology to the next degree™

Gentherm — Q3 2020 Earnings Presentation on 6ix